Brendan Pierson

Two lawsuits last month accusing Microsoft of misleading investors about its AI business highlight the risks of companies making bold AI claims in the face of the technology's rapid and unpredictable development, attorneys say.

The FTC marked the United States' 250th anniversary with warning letters against seven companies over what it said were false claims about their products' U.S. origin—a sign that it will continue to prioritize the issue and take a broad view of such claims, even if it does not always lead to enforcement action.

The FTC's record $12 million settlement with Edwards Lifesciences and Genesis MedTech Group over claims that the companies structured a 2024 transaction to avoid antitrust reporting requirements is a strong warning to companies contemplating future deals.

The FTC's record $12 million settlement with Edwards Lifesciences and Genesis MedTech Group over claims that the companies structured a 2024 transaction to avoid antitrust reporting requirements is a strong warning to companies contemplating future deals.

membership Law.com Pro Companies in Illinois continue to face risk from the state's strict biometric privacy law as plaintiffs file

Companies in Illinois continue to face risk from the state’s strict biometric privacy law as plaintiffs file new kinds of lawsuits, despite a 2024 amendment that reduced potential damages under the law and a recent court ruling that the amendment was retroactive.

A federal appeals court's recent decision rejecting a longstanding National Labor Relations Board policy in light of the Supreme Court's landmark Loper Bright Enterprises v. Raimondo ruling could signal a major shakeup in federal labor law going forward.

membership Law.com Pro The U.S. Federal Trade Commission has finalized its long-awaited settlement with CVS Caremark, offering

membership Law.com Pro Two recent surges of lawsuits over patient data breaches underscore a growing double threat faced by healthcare

The U.S. Federal Trade Commission has finalized its long-awaited settlement with CVS Caremark, offering further clarity on how the agency aims to reshape the pharmacy benefit manager (PBM) industry.